Publications and presentations

Peer-reviewed publications
File Link Impact

Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis

Pensée Wu, Caroline van den Berg, Zarko Alfirevic, Shaughn O’Brien, Maria Röthlisberger, Philip Newton Baker, Louise C. Kenny, Karolina Kublickiene and Johannes J. Duvekot. Int. J. Mol. Sci. 2015, 16(9), 23035-23056.

International Journal of Molecular Sciences

Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments

Neily Zakiyah, Maarten J. Postma, Philip N. Baker, Antoinette D. I. van Asselt, On behalf of the IMPROvED Consortium. PharmacoEconomics 2015:291. Published online: 06 Jun 2015.

PDF Pharmaco-Economics

Preeclampsia risk stratification early in pregnancy: Levering a promising metabolomics discovery in a LC–MS based clinical assay

Bond, Liz et al. In: Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, Volume 5, Issue 1, 82. January 2015

Pregnancy Hypertension

A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED)

Kate Navaratnam, Zarko Alfirevic, Philip N Baker, Christian Gluud, Berthold Grüttner, Karolina Kublickiene, Gerda Zeeman and Louise C Kenny. BMC Pregnancy and Childbirth 2013, 13:226

PDF BMC Pregnancy and Childbirth
Conference presentations
File Link

Preeclampsia risk stratification early in pregnancy: First results of a new LC-MS based multiplex metabolite assay

Liz Bond, Grégoire Thomas, Caroline Nolan, Peter Christensen,Phil Baker, Louise Kenny, Robin Tuytten. Presented at the MSACL 2015 EU, Salzburg, Austria: Sept 8-11.

Poster presentations
File Link

Preeclampsia risk stratification early in pregnancy: First results of a new LC-MS based multiplex metabolite assay

Liz Bond, Grégoire Thomas, Caroline Nolan, Peter Christensen,Phil Baker, Louise Kenny, Robin Tuytten. Presented at the ISSHP 2015, Budapest, Hungary.

Quality within the EU-FP7 IMPROvED Biobank

EM Guiney-Snapes, PN Baker, Z Alfirevic, M Kublickas, JJ Duvekot, B Grüttner, C Gluud, S Marthinsson, K Verleysen, C Garvey, J Müller and LC Kenny. Presented at the ESBB Biobanking conference in Leipzig, Germany, 21 - 24 October, 2014.

PDF

PREECLAMPSIA RISK STRATIFICATION EARLY IN PREGNANCY: LEVERAGING A PROMISING METABOLOMICS DISCOVERY INTO A LC-MS BASED CLINICAL ASSAY

Liz Bond, Caroline Nolan, Katy Hyland, Charline Lenaerts, Philip N. Baker, Louise C. Kenny, Robin Tuytten.

Presented at the ISSHP 2014, New Orleans, USA.

PDF

Economic Assessment of Pre-eclampsia: Screening, Diagnosis, Treatment Options, and Long Term Outcomes

Zakiyah N, van Asselt ADI, Baker PN, Postma MJ on behalf of the IMPROvED consortium.
Presented at the ISPOR 17th Annual Congress 2014, Amsterdam, PIH14.

PDF

Preeclampsia risk stratification early in pregnancy: Conversion of a promising metabolomics discovery into a LC-MS based clinical assay

Liz Bond, CharlineLenaerts, Christopher Benton, Phil Baker, Louise Kenny, Robin Tuytten.
Presented at the MSACL 2014 EU, Salzburg, Austria: Sept 2-5.

PDF

IMPROvED: A multicentre clinical study to develop a predictive blood test for pre-eclampsia

Boel Niklasson, Karolina Kublickiene, Marius Kublickas, Caroline van den Berg, Johannes Duvekot, Zarko Alfirevic, Shaughn O'Brien, Philip Baker, Christoph Berg, Berthold Grüttner, Louise Kenny. Presented at the 39th Nordic Congress of Obstetrics and Gynecology, June 2014 Stockholm.

PDF